Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioAPI is a synthetic biology company that focuses on creating a standardized interface for programming biological systems. The company aims to bridge the gap between computer science and biology by developing "Biological Application Programming Interfaces" (BioAPIs) that allow researchers to design and execute biological experiments with the same ease as writing software. Their platform is designed to streamline the engineering of organisms for various applications, including drug discovery, diagnostics, and industrial biotechnology. By providing a high-level abstraction for complex biological processes, BioAPI seeks to accelerate the pace of innovation in the life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioAPI.